[ET Net News Agency, 10 March 2026] HANSOH PHARMA (03692) rose 3.1% to HK$34.78.
It hits an intra-day high of HK$34.78, breaking above the 10-D SMA of HK$33.8, and an intra-day low of HK$33.64. The total shares traded was 1.3 million, with a value of HK$44.91m. The active buy/sell ratio is 74:26, with net buying turnover of HK$19.49m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$1.02m, with volume weighted average price of HK$34.554. TFI SEC & FUTURES accounts for greatest net responsive selling turnover of HK$3.35m, with volume weighted average price of HK$34.515. The stock has risen a combined 8.7% over the past 4 consecutive trading days.
The Hang Seng Index now rose 397 points, or 1.6% to 25,805.
Basic Information| Nominal | 34.780 | % Chg | +3.14% |
| High | 34.780 | Low | 33.640 |
| Shares Tr | 1.3m | Turnover | 44.91m |
| 10-D SMA | 33.800 | %H.V | 37.526 |
| 20-D SMA | 35.295 | VWAP | 34.428 |
| 50-D SMA | 37.667 | RSI14 | 44.953 |
Status: Breaking above the 10-D SMA, active buy/sell ratio is 74:26, with net buying turnover of HK$19.49m, rising a combined 8.7% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 34.78 | +3.14 |
| SIHUAN PHARM (00460) | 1.51 | +2.72 |
| GRAND PHARMA (00512) | 7.37 | +2.65 |
| SINO BIOPHARM (01177) | 6.25 | +1.30 |
| HENGRUI PHARMA (01276) | 66.55 | +2.78 |
| LIVZON PHARMA (01513) | 28.80 | +0.49 |
| LUYE PHARMA (02186) | 2.50 | +1.63 |
| FOSUN PHARMA (02196) | 20.02 | +2.35 |
| SH PHARMA (02607) | 11.40 | +0.71 |
| CHINARES PHARMA (03320) | 4.57 | +0.44 |
(ed)
